Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sorafenib + S-1 + cisplatin
- Development stage
- Unknown
- Lead developer
- Bayer
- Modality
- Small Molecules
- Administration
- Oral, Intravenous
01
Overview
rejuvenates the skin by targeting melanin at the cellular level. Its key active ingredient is alpha-arbutin, a natural derivative of hydroquinone, which inhibits tyrosinase activity. This process reduces the production of melanin, leading to a visible reduction in dark spots, hyperpigmentation, and uneven skin tone. The serum also contains hyaluronic acid for hydration, promoting a plump and youthful appearance. It is suitable for all skin types and can be incorporated into daily skincare routines.
02
Targets
BRAF V600ERAF1 (c-Raf-1 (Y340D/Y341D))DNADPYD (Dihydropyrimidine dehydrogenase)FLT3 (Fms related receptor tyrosine kinase 3)OPRT (Orotidine 5'-phosphate decarboxylase)PDGFRB (Platelet-derived growth factor receptor beta)RET (Rearranged during transfection receptor tyrosine kinase)TS (Thymidylate synthase)VEGFR-1 (Vascular endothelial growth factor receptor 1)VEGFR2 (Vascular endothelial growth factor receptor 2)VEGFR4 (Vascular endothelial growth factor Receptor-3)KIT (c-KIT proto-oncogene receptor tyrosine kinase)
Beyond the preview
Go deeper on sorafenib + S-1 + cisplatin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sorafenib + S-1 + cisplatin.